Literature DB >> 28204757

Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study.

Omri Weisman1,2, Yael Guri1, Raquel E Gur3,4, Donna M McDonald-McGinn5,6, Monica E Calkins3, Sunny X Tang3, Beverly Emanuel5,6, Elaine H Zackai5,6, Stephan Eliez7, Maude Schneider7, Marie Schaer7, Wendy R Kates8, Kevin M Antshel9, Wanda Fremont8, Vandana Shashi10, Stephen R Hooper11, Marco Armando7,12, Stefano Vicari12, Maria Pontillo12, Leila Kushan13, Maria Jalbrzikowski14, Carrie E Bearden13, Joseph F Cubells15,16, Opal Y Ousley15,16, Elaine F Walker17, Tony J Simon18, Joel Stoddard18, Tara A Niendam18, Marianne B M van den Bree19, Doron Gothelf1,2.   

Abstract

Nearly one-third of individuals with 22q11.2 deletion syndrome (22q11.2DS) develop a psychotic disorder during life, most of them by early adulthood. Importantly, a full-blown psychotic episode is usually preceded by subthreshold symptoms. In the current study, 760 participants (aged 6-55 years) with a confirmed hemizygous 22q11.2 microdeletion have been recruited through 10 medical sites worldwide, as part of an international research consortium. Of them, 692 were nonpsychotic and with complete measurement data. Subthreshold psychotic symptoms were assessed using the Structured Interview for Prodromal Syndromes (SIPS). Nearly one-third of participants met criteria for positive subthreshold psychotic symptoms (32.8%), less than 1% qualified for acute positive subthreshold symptoms, and almost a quarter met criteria for negative/disorganized subthreshold symptoms (21.7%). Adolescents and young adults (13-25 years) showed the highest rates of subthreshold psychotic symptoms. Additionally, higher rates of anxiety disorders and attention deficit/hyperactivity disorder (ADHD) were found among the study participants with subthreshold psychotic symptoms compared to those without. Full-scale IQ, verbal IQ, and global functioning (GAF) scores were negatively associated with participants' subthreshold psychotic symptoms. This study represents the most comprehensive analysis reported to date on subthreshold psychosis in 22q11.2DS. Novel findings include age-related changes in subthreshold psychotic symptoms and evidence that cognitive deficits are associated with subthreshold psychosis in this population. Future studies should longitudinally follow these symptoms to detect whether and how early identification and treatment of these manifestations can improve long-term outcomes in those that eventually develop a psychotic disorder.
© The Author 2017. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  DiGeorge syndrome; IQ; anxiety disorder; attention deficit/hyperactivity disorder (ADHD); global assessment of functioning (GAF); structured interview for prodromal syndromes; subthreshold psychotic symptoms; velocardiofacial syndrome

Mesh:

Year:  2017        PMID: 28204757      PMCID: PMC5581907          DOI: 10.1093/schbul/sbx005

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  41 in total

1.  Preliminary structure and predictive value of attenuated negative symptoms in 22q11.2 deletion syndrome.

Authors:  Maude Schneider; Martial Van der Linden; Bronwyn Glaser; Eleonora Rizzi; Sophie P Dahoun; Christine Hinard; Lucia Bartoloni; Stylianos E Antonarakis; Martin Debbané; Stephan Eliez
Journal:  Psychiatry Res       Date:  2012-02-27       Impact factor: 3.222

2.  Subthreshold psychotic symptoms in 22q11.2 deletion syndrome.

Authors:  Sunny X Tang; James J Yi; Tyler M Moore; Monica E Calkins; Christian G Kohler; Daneen A Whinna; Margaret C Souders; Elaine H Zackai; Donna M McDonald-McGinn; Beverly S Emanuel; Warren B Bilker; Ruben C Gur; Raquel E Gur
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-06-19       Impact factor: 8.829

3.  Age matters in the prevalence and clinical significance of ultra-high-risk for psychosis symptoms and criteria in the general population: Findings from the BEAR and BEARS-kid studies.

Authors:  Benno G Schimmelmann; Chantal Michel; Alexandra Martz-Irngartinger; Caroline Linder; Frauke Schultze-Lutter
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

4.  Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning.

Authors:  Marco Armando; Paolo Girardi; Stefano Vicari; Deny Menghini; Maria Cristina Digilio; Maria Pontillo; Riccardo Saba; Luigi Mazzone; Ashleigh Lin; Claudia M Klier; Miriam R Schäfer; G Paul Amminger
Journal:  Schizophr Res       Date:  2012-05-23       Impact factor: 4.939

Review 5.  The psychosis high-risk state: a comprehensive state-of-the-art review.

Authors:  Paolo Fusar-Poli; Stefan Borgwardt; Andreas Bechdolf; Jean Addington; Anita Riecher-Rössler; Frauke Schultze-Lutter; Matcheri Keshavan; Stephen Wood; Stephan Ruhrmann; Larry J Seidman; Lucia Valmaggia; Tyrone Cannon; Eva Velthorst; Lieuwe De Haan; Barbara Cornblatt; Ilaria Bonoldi; Max Birchwood; Thomas McGlashan; William Carpenter; Patrick McGorry; Joachim Klosterkötter; Philip McGuire; Alison Yung
Journal:  JAMA Psychiatry       Date:  2013-01       Impact factor: 21.596

6.  COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome.

Authors:  Doron Gothelf; Stephan Eliez; Tracy Thompson; Christine Hinard; Lauren Penniman; Carl Feinstein; Hower Kwon; Shuting Jin; Booil Jo; Stylianos E Antonarakis; Michael A Morris; Allan L Reiss
Journal:  Nat Neurosci       Date:  2005-10-23       Impact factor: 24.884

7.  Clinical characteristics of schizophrenia associated with velo-cardio-facial syndrome.

Authors:  D Gothelf; A Frisch; H Munitz; R Rockah; N Laufer; T Mozes; H Hermesh; A Weizman; M Frydman
Journal:  Schizophr Res       Date:  1999-01-11       Impact factor: 4.939

8.  Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.

Authors:  Joel Stoddard; Tara Niendam; Robert Hendren; Cameron Carter; Tony J Simon
Journal:  Schizophr Res       Date:  2010-01-06       Impact factor: 4.939

9.  Neurocognitive growth charting in psychosis spectrum youths.

Authors:  Ruben C Gur; Monica E Calkins; Theodore D Satterthwaite; Kosha Ruparel; Warren B Bilker; Tyler M Moore; Adam P Savitt; Hakon Hakonarson; Raquel E Gur
Journal:  JAMA Psychiatry       Date:  2014-04       Impact factor: 21.596

Review 10.  The Child and Adolescent Psychiatric Assessment (CAPA).

Authors:  A Angold; M Prendergast; A Cox; R Harrington; E Simonoff; M Rutter
Journal:  Psychol Med       Date:  1995-07       Impact factor: 7.723

View more
  15 in total

1.  Abnormalities in white matter tracts in the fronto-striatal-thalamic circuit are associated with verbal performance in 22q11.2DS.

Authors:  Carina Heller; Saskia Steinmann; James J Levitt; Nikos Makris; Kevin M Antshel; Wanda Fremont; Ioana L Coman; Stefan R Schweinberger; Thomas Weiß; Sylvain Bouix; Marek R Kubicki; Wendy R Kates; Zora Kikinis
Journal:  Schizophr Res       Date:  2020-10-23       Impact factor: 4.939

2.  Early language measures associated with later psychosis features in 22q11.2 deletion syndrome.

Authors:  Cynthia B Solot; Tyler M Moore; Terrence Blaine Crowley; Marsha Gerdes; Edward Moss; Daniel E McGinn; Beverly S Emanuel; Elaine H Zackai; Sean Gallagher; Monica E Calkins; Kosha Ruparel; Ruben C Gur; Donna M McDonald-McGinn; Raquel E Gur
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2020-07-27       Impact factor: 3.568

3.  High Rates of Genetic Diagnosis in Psychiatric Patients with and without Neurodevelopmental Disorders: Toward Improved Genetic Diagnosis in Psychiatric Populations.

Authors:  Joyce So; Venuja Sriretnakumar; Jessica Suddaby; Brianna Barsanti-Innes; Hanna Faghfoury; Timothy Gofine
Journal:  Can J Psychiatry       Date:  2020-06-04       Impact factor: 4.356

Review 4.  Understanding the pediatric psychiatric phenotype of 22q11.2 deletion syndrome.

Authors:  Ania M Fiksinski; Maude Schneider; Clodagh M Murphy; Marco Armando; Stefano Vicari; Jaume M Canyelles; Doron Gothelf; Stephan Eliez; Elemi J Breetvelt; Celso Arango; Jacob A S Vorstman
Journal:  Am J Med Genet A       Date:  2018-09-08       Impact factor: 2.802

5.  Abnormal Auditory Processing and Underlying Structural Changes in 22q11.2 Deletion Syndrome.

Authors:  Lucia-Manuela Cantonas; Valentina Mancini; Tonia A Rihs; Vincent Rochas; Maude Schneider; Stephan Eliez; Christoph M Michel
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

Review 6.  Genetic analysis of deep phenotyping projects in common disorders.

Authors:  Elliot S Gershon; Godfrey Pearlson; Matcheri S Keshavan; Carol Tamminga; Brett Clementz; Peter F Buckley; Ney Alliey-Rodriguez; Chunyu Liu; John A Sweeney; Sarah Keedy; Shashwath A Meda; Neeraj Tandon; Rebecca Shafee; Jeffrey R Bishop; Elena I Ivleva
Journal:  Schizophr Res       Date:  2017-10-20       Impact factor: 4.939

7.  Positive psychotic symptoms are associated with divergent developmental trajectories of hippocampal volume during late adolescence in patients with 22q11DS.

Authors:  Valentina Mancini; Corrado Sandini; Maria C Padula; Daniela Zöller; Maude Schneider; Marie Schaer; Stephan Eliez
Journal:  Mol Psychiatry       Date:  2019-06-04       Impact factor: 15.992

8.  Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study.

Authors:  Maria Rogdaki; Céline Devroye; Mariasole Ciampoli; Mattia Veronese; Abhishekh H Ashok; Robert A McCutcheon; Sameer Jauhar; Ilaria Bonoldi; Maria Gudbrandsen; Eileen Daly; Therese van Amelsvoort; Marianne Van Den Bree; Michael J Owen; Federico Turkheimer; Francesco Papaleo; Oliver D Howes
Journal:  Mol Psychiatry       Date:  2021-05-12       Impact factor: 15.992

9.  A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium.

Authors:  R E Gur; A S Bassett; D M McDonald-McGinn; C E Bearden; E Chow; B S Emanuel; M Owen; A Swillen; M Van den Bree; J Vermeesch; J A S Vorstman; S Warren; T Lehner; B Morrow
Journal:  Mol Psychiatry       Date:  2017-08-01       Impact factor: 15.992

10.  Inter-rater reliability of subthreshold psychotic symptoms in individuals with 22q11.2 deletion syndrome.

Authors:  Tyler M Moore; Deby Salzer; Doron Gothelf; Carrie E Bearden; Monica E Calkins; Wendy R Kates; Leila Kushan; Robert Sean Gallagher; Dafna Sofrin Frumer; Ronnie Weinberger; Donna M McDonald-McGinn; Raquel E Gur
Journal:  J Neurodev Disord       Date:  2021-06-14       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.